Hypoglycemic effect of Astragalus Cuban Experimental Study of Powder.docVIP

 PAGE \* MERGEFORMAT 8 Hypoglycemic effect of Astragalus Cuban Experimental Study of Powder Of: Chen Yanfen, Wang Chunyi, LI Wei-min, GAO Ying, Wu Qinghe, Ye Xuelan [Abstract] Objective To study the Cuban side effects of Astragalus powder on blood sugar. Methods of streptozotocin (STZ)-induced diabetes and hyperglycemia caused by epinephrine in mice models were scattered on the blood glucose astragalus and impaired glucose tolerance of mice , and observe the astragalus powder on blood glucose and glucose tolerance in normal mice. The results can reduce the dose of astragalus powder in STZ diabetic mice, fasting blood glucose, and high dose can improve glucose tolerance in STZ diabetic mice, caused by lower epinephrine high blood sugar, Astragalus Powder high, medium and low-dose continuous administration of 3 weeks on blood glucose and glucose tolerance in normal mice had no effect. Conclusion Astragalus Powder has a hypoglycemic effect, for the clinical treatment of diabetes and its complications provides experimental basis. [Keywords:] astragalus powder; glucose; mice; pharmacology Abstract: Objective To study the effects of Huangqisan on blood glucose level in mice.Methods Diabetic mice induced by streptozotocin (STZ), hyperglycemia mice caused by adrenalin and normal mice were used to study the effects of Huangqisan on blood glucose level and glucose tolerance in pathological or normal state.Results The moderate dose of Huangqisan decreased fasted blood glucose, high dose and moderate dose improved glucose tolerance in STZ induced diabetic mice; high and moderate doses also lowered blood glucose in adrenaline induced hyperglycemia mice; however, Huangqisan showed no obvious effects on blood glucose level and glucose tolerance in normal mice after administration for three weeks.Conclusion Huangqisan had positive hypoglycemic effects in the study, providing experimental basis for the clinical utilization in the treatment of diabetes and its compli